...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith new VP
Reply New Message
Prev Message Back To Forum Threaded View Next Message

It appears that the new VP hire is a done deal. Edward van der Horst's LinkedIn profile lists the following:

"Vice President Discovery Biology & Preclinical Development

Zenith Epigenetics Corp.

Jul 2017 – Present

San Francisco Bay Area"

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply